Both in R&D — Physical & Biological Sciences
MaxCyte vs OneMedNet
Over the past year MXCT returned +10.3% and ONMD returned −79.7%; their daily moves had a correlation of 0.04.
MXCT +10.3% ONMD −79.7%Growth of $1, one year, split-adjusted
| Metric | MXCT | ONMD |
|---|---|---|
| Price | $1.71 | $4.46 |
| Market cap | $176.5M | $26.0M |
| Today | +11.04% | +1.36% |
| 1 month | +44.9% | −14.4% |
| 6 months | +109.1% | −58.7% |
| Year to date | +10.3% | −59.5% |
| 1 year | +11.0% | −80.4% |
| Revenue growth (YoY) | −14.5% | +88.4% |
| Gross margin | 77.0% | −193.5% |
| Net margin | −122.0% | −743.8% |
| P/E (TTM) | — | — |
| Price / sales | 5.7× | 17.8× |
| Net cash | $105.7M | -$343.0K |
| Dividend yield | — | — |
| Volatility (60d) | 78.8% | 699.6% |
| Short % of float | 2.0% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).